Ohio State's sarcoma team uses a comprehensive approach to provide cutting-edge care to each patient with this rare type of cancer. Approximately 12,000 Americans are diagnosed with a sarcoma each year, some of which affect the body’s soft tissue, while other forms are found in bones, known as osteosarcomas. Soft tissue sarcomas typically present as painless masses in unusual places on the body, while osteosarcomas hurt when patients use affected bones. While sarcomas are relatively rare, members of the OSUCCC – James’ dedicated team span a broad range of disciplines, from medical, surgical and radiation oncologists to orthopedic and reconstructive surgeons, molecular and biological pathologists, genetic scientists and more — all specializing in sarcoma (and only sarcoma) research, prevention, detection, treatment and cure. “The members of our very large, comprehensive team meet every week to go over all of the new patients and make sure that people have access to the appropriate care, including the latest cutting-edge treatments,” says Joel Mayerson, MD, the director of the sarcoma team at the OSUCCC – James.